XClose

UCL Health

Home
Menu

Internal Capital Equipment Fund (CEF) Calls

UK Research & Innovation (UKRI) allocate Research Capital Investment Fund (RCIF) funding to universities including UCL each year. RCIF is intended to support universities to invest in research capital for the benefit of the university and its researchers. A proportion of UCL’s RCIF allocation to the Life and Medical Science Facilities is used to fund CEF calls.

Open Calls


Capital Equiment Fund (CEF7)

Background

The Capital Equipment Fund Call (CEF7) is open to all Divisions and Institutes within the faculties of Life, Brain, Medical, and Population Health Sciences, and is intended to support the purchase of strategically important research capital equipment. We expect many of the successful applications to be for major equipment within multi-user facilities such as members of the UCL Science and Technology Platforms (STPs) or within other existing shared research facilities.

CEF7 funding is provided via a UKRI Research England allocation (Research Capital Investment Fund – RCIF) to UCL for the 2024/25 Financial Year. As a result, all equipment purchased through CEF7 must be on UCL premises no later than 31 July 2025.

Funding

Applications to CEF7 are expected to be in excess of £50k. Eligible costs include the cost of equipment purchase, installation, shipping, taxes (VAT or import tax) where chargeable, and standard warranties. For full funding eligibility and requirements please see the full CEF guidelines or contact Nadine Simons-Weidenmaier (n.simons-weidenmaier@ucl.ac.uk)

Please apply here: CEF7 Application Form

Important dates

Deadline to contact STP Academic Lead (if applicable): Friday 28th June 2024
Deadline for applications and Divisional/Institutel rankings: Thursday 12th September 2024
Award outcome announcement: End of November 2024
Equipment delivery deadline: Wednesday 31st July 2025

Supporting documents